ContractExclusive Distribution and Supply Agreement • May 5th, 2020
EX-10.22 27 exhibit1022s-1.htm EXHIBIT 10.22 Exhibit 10.22 EXCLUSIVE DISTRIBUTION AND SUPPLY AGREEMENT This EXCLUSIVE DISTRIBUTION AND SUPPLY AGREEMENT (this “Agreement”) is entered into as of November 30, 2017 (the “Effective Date”) by and between EVOLUS, INC. a Delaware Corporation (“EVOLUS”), and CLARION MEDICAL TECHNOLOGIES INC., a body corporate, incorporated under the Ontario Business Corporations Act (“DISTRIBUTOR”). BACKGROUND WHEREAS, EVOLUS is party to that certain License and Supply Agreement, dated as of September 30, 2013, by and between Daewoong Pharmaceutical Co., Ltd. (“Daewoong”) and EVOLUS, as amended from time to time (the “Daewoong Agreement”) pursuant to which it has an exclusive right and license to import, distribute, promote, market, develop, offer for sale and otherwise commercialize or exploit Agreement Products in territories including the Territory (as defined below); WHEREAS, EVOLUS desires to grant to DISTRIBUTOR, and DISTRIBUTOR desires to receive from EV
AGREEMENTExclusive Distribution and Supply Agreement • August 15th, 2005 • Strategic Diagnostics Inc/De/ • Miscellaneous chemical products • Delaware
Certain identified information has been excluded from the exhibit because it both (i) is not material and (ii) is the type that the company treats as private or confidential.] Exclusive Distribution and Supply AgreementExclusive Distribution and Supply Agreement • January 31st, 2023 • Sonoma Pharmaceuticals, Inc. • Pharmaceutical preparations
This Exclusive Distribution and Supply Agreement is entered into as of January 26, 2023 (the “Effective Date”) by and between Sonoma Pharmaceuticals, Inc., a Delaware corporation having a place of business at 5445 Conestoga Court, Unit 150, Boulder, Colorado 80301 (“Supplier”) and Daewoong Pharmaceutical Co., Ltd., a having a place of business at 12, Bongeunsa-ro 114-gil Gangnam-gu, Seoul, Republic of Korea (“Distributor”).
Exclusive Distribution and Supply AgreementExclusive Distribution and Supply Agreement • August 15th, 2012 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • New York
This Exclusive Distribution and Supply Agreement is entered into as of the latest date set forth on the signature lines below by and between, on the one part, Oculus Innovative Sciences, Inc., a Delaware corporation having a place of business at 1129 No. McDowell Boulevard, Petaluma, California, USA 94954 (hereinafter referred to as “Oculus”) and Oculus Technologies of Mexico, S.A. de C.V. (hereinafter referred to as “Manufacturer”), a limited liability corporation organized under the laws of Mexico, having a place of business at Industria Vidriera 81, Fracc. Industrial Zapopan Norte, 45130 Zapopan, Jalisco, Mexico, and, on the other part, More Pharma Corporation, S. de R.L. de C.V. (hereinafter referred to as “More Pharma”), a limited liability company organized under the laws of Mexico, having a place of business at Av. Ejército Nacional 926, Interior 203 Col. Los Morales, Sección Palmas 11540, Mexico City, Mexico.
Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.] EXCLUSIVE DISTRIBUTION AND SUPPLY AGREEMENTExclusive Distribution and Supply Agreement • December 10th, 2020 • Sonoma Pharmaceuticals, Inc. • Pharmaceutical preparations • Georgia
This Exclusive Distribution and Supply Agreement is entered into as of December 4, 2020 (the “Effective Date”) by and between Sonoma Pharmaceuticals, Inc., a Delaware corporation having a place of business at 645 Molly Lane, Suite 150, Woodstock, GA 30189 (“Supplier”) and Crown Laboratories, Inc., a Delaware corporation, having a place of business at 207 Mockingbird Lane, Johnson City, TN 37604 (“Distributor”).
Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if disclosed.] EXCLUSIVE DISTRIBUTION AND SUPPLY AGREEMENTExclusive Distribution and Supply Agreement • March 31st, 2021 • Sonoma Pharmaceuticals, Inc. • Pharmaceutical preparations • Georgia
This Exclusive Distribution and Supply Agreement is entered into as of March 26, 2021 (the “Effective Date”) by and between Sonoma Pharmaceuticals, Inc., a Delaware corporation having a place of business at 645 Molly Lane, Suite 150, Woodstock, GA 30189 (“Supplier”) and EMC Pharma, LLC, a Missouri limited liability company, having a place of business at 11551 Adie Road, Maryland Heights, MO 63043(“Distributor”).
EXCLUSIVE DISTRIBUTION AND SUPPLY AGREEMENTExclusive Distribution and Supply Agreement • June 30th, 2016 • Milestone Scientific Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
This Exclusive Distribution and Supply Agreement (this “Agreement”) is entered into as of June 20, 2016 by and among Milestone Scientific, Inc. (“Milestone”, but solely for the purposes of Section 1.1(b) and Section 13.2), Wand Dental, Inc. (“Supplier”) and Henry Schein, Inc. (“HSI”).
